Drugs that contain Dienogest; Estradiol Valerate

1. Natazia patents expiration

NATAZIA's oppositions filed in EPO
Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US6884793 BAYER HLTHCARE Combination preparation for contraception based on natural estrogens
Oct, 2016

(7 years ago)

US6133251 BAYER HLTHCARE Combination compound for contraception based on natural estrogen
Oct, 2016

(7 years ago)

US8071577 BAYER HLTHCARE Multi-phase contraceptive preparation based on a natural estrogen
May, 2026

(2 years from now)

US8153616 BAYER HLTHCARE Combination preparation for oral contraception and oral therapy of dysfunctional uterine bleeding containing estradiol valerate and dienogest and method of using same
Jan, 2028

(3 years from now)

Drug Exclusivity Drug Exclusivity Expiration
New Indication(I-648) Mar 14, 2015
New Product(NP) May 06, 2013

Market Authorisation Date: 06 May, 2010

Treatment: Prevention of pregnancy; Treatment of heavy menstrual bleeding in women without organic pathology who choose to use an oral contraceptive as their method of contraception


How can I launch a generic of NATAZIA before it's drug patent expiration?
More Information on Dosage

NATAZIA family patents

Family Patents